🇺🇸 Detemir insulin in United States

43 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 8 reports (18.6%)
  2. Hypoglycaemia — 5 reports (11.63%)
  3. Cerebrovascular Accident — 4 reports (9.3%)
  4. Diarrhoea — 4 reports (9.3%)
  5. Drug Ineffective — 4 reports (9.3%)
  6. Extradural Haematoma — 4 reports (9.3%)
  7. Fall — 4 reports (9.3%)
  8. Headache — 4 reports (9.3%)
  9. Anaemia Vitamin B12 Deficiency — 3 reports (6.98%)
  10. Blood Glucose Decreased — 3 reports (6.98%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Detemir insulin approved in United States?

Detemir insulin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Detemir insulin in United States?

The University of Texas Health Science Center, Houston is the originator. The local marketing authorisation holder may differ — check the official source linked above.